Aminolevulinic acid photodynamic therapy: medical evidence for its expanded use

References

• Raab O. Ueber die Wirkung fluoreszierenden Stoffe auf Infusorien. Z. Biol.39, 524–526 (1900).
   Google Scholar
• Von Tappeiner H, Jodblauer A. Uber die Wirkung der photodynamischen (fluorescierenden) Staffe auf Protozoen und Enzyme. Dtsch. Arch. Klin. Med.80, 427–487 (1904).
   Google Scholar
• Jesionek A, Von Tappeiner H. Behandlung der Hautcarcinome nut fluorescierenden Stoffen. Dtsch. Arch. Klin. Med.85, 223–227 (1905).
   Google Scholar
• Hausman W. Die Sensibilisierende Wirkung des hamatoporphyrins. Biochem. Z.XXX, 276–316 (1911).
   Google Scholar
• Meyer-Betz F. Untersuchungen uber die Biologische (photodynamische) Wirkung des hamatoporphyrins und anderer Derivative des Blut-und Gallenfarbstoffs. Dtsch. Arch. Klin. Med.112, 476–503 (1913).
   Google Scholar
• Auler H, Banzer G. Untersuchungen ueber die Rolle der Porphyrine bei geschwulstkranken Menschen und Tieren. Z. Krebsforsch.53, 65–68 (1942).
   Google Scholar
• Figge FHJ, Weiland GS, Manganiello LDJ. Cancer detection and therapy. Affinity of neoplastic embryonic and traumatized tissue for porphyrins and metalloporphyrins. Proc. Soc. Exp. Biol. Med.68, 640 (1948).
   PubMed Web of Science ®Google Scholar
• Dougherty TJ, Kaufman JE, Goldfarb A et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res.38, 2628–2635 (1978).
   PubMed Web of Science ®Google Scholar
• Kennedy JC, Pottier RH, Pross DC et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B6, 143–148 (1990).
   PubMed Web of Science ®Google Scholar
• Gold MH, Goldman MP. 5-aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatol. Surg.30, 1077–1084 (2004).
   PubMed Web of Science ®Google Scholar
• Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J. Clin. Laser Med. Surg.14, 289–304 (1996).
   PubMedGoogle Scholar
• Kennedy J, Pottier R. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B. Biol.14, 275–292 (1992).
   PubMed Web of Science ®Google Scholar
• Taub A. Photodynamic therapy in dermatology: history and horizons. J. Drugs Dermatol.3(1 Suppl.), S8–S25 (2004).
   PubMedGoogle Scholar
• Cockerell CJ, Wharton JR. New histopathological classification of actinic keratosis (incipient intraepidermal squamous cell carcinoma). J. Drugs Dermatol.4, 462–467 (2005).
   PubMedGoogle Scholar
• Gold MH. The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in photoaging. Cutis69, S8–S13 (2002).
   PubMedGoogle Scholar
• Jeffes EW, McCullough JL, Weinstein GD, Kaplan R, Glazer SD, Taylor JR. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J. Am. Acad. Dermatol.45, 96–104 (2001).
   PubMed Web of Science ®Google Scholar
• Piacquadio DJ, Chen DM, Farber HF et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch. Dermatol.40(1), 41–44 (2004).
   Google Scholar
• Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch. Dermatol.134(2), 207–214 (1998).
   PubMed Web of Science ®Google Scholar
• Freeman M, Vinciullo C, Francis D et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J. Dermatolog. Treat.14, 99–106 (2003).
   PubMedGoogle Scholar
• Pariser DM, Lowe NJ, Stewart DM et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J. Am. Acad. Dermatol.48, 227–232 (2003).
   PubMed Web of Science ®Google Scholar
• Rhodes LE, de Rie M, Enstrom Y et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch. Dermatol.140(1), 17–23 (2004).
   PubMed Web of Science ®Google Scholar
• Wulf HC, Philipsen P. Allergic contact dermatitis to 5-aminolaevulinic acid methylester but not to 5-aminolaevulinic acid after photodynamic therapy. Br. J. Dermatol.150(1), 143–145 (2004).
   Google Scholar
• Hauschild A, Lischner S, Lange-Asschenfeldt B, Egberts F. Treatment of actinic cheilitis using photodynamic therapy with methylaminolevulinate: report of three cases. Dermatol. Surg.31(10), 1344–1347 (2005).
   Google Scholar
• Lee MR, Ryman W. Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy. Australas. J. Dermatol.46(3), 196–198 (2005).
   PubMedGoogle Scholar
• Dragieva G, Prinz BM, Hafner J et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br. J. Dermatol.151(1), 196–200 (2004).
   PubMedGoogle Scholar
• Touma D, Yaar M, Whitehead S et al. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch. Dermatol.140, 33–40 (2004).
   PubMedGoogle Scholar
• Ruiz-Rodriquez R, Sanz-Sanchez T, Cordobo S. Photodynamic photorejuvenation. Dermatol. Surg.28, 742–744 (2002).
   Google Scholar
• Goldman MP, Atkin D, Kincad S. PDT/ALA in the treatment of actinic damage: real world experience. J. Lasers Surg. Med.14(S), 24 (2002).
   Google Scholar
• Avram DK, Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J. Drugs Dermatol.3, S36–S39 (2004).
   PubMedGoogle Scholar
• Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch. Dermatol.139(10), 1313–1320 (2003).
   PubMedGoogle Scholar
• Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic chelitis. J. Drugs Dermatol.3(5), 548–551 (2004).
   PubMedGoogle Scholar
• Alster TS, Tanzi EL, Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J. Drugs Dermatol.4, 35–38 (2005).
   PubMedGoogle Scholar
• Key DJ. Aminolevulinic acid-pulsed dye laser photodynamic therapy for the treatment of Photoaging. Cosm. Derm.18, 31–36 (2005).
   Google Scholar
• Marmur ES, Phelps R, Goldberg DJ. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J. Cosmet. Laser Ther.7(1), 21–24 (2005).
   PubMedGoogle Scholar
• Bhatia AC, Dover JS. Adjunctive use of topical aminolevulinic acid with intense pulsed light in the treatment of photoaging. Presentation – Controversies and Conversations in Cutaneous Laser Surgery. Mt. Tremblant, Canada (2004).
   Google Scholar
• Gold MH, Bradshaw VL, Boring MM et al. A split-face comparison study of ALA-PDT with intense pulsed light versus intense pulse light alone for photodamage/photorejuvenation. Dermatol. Surg. (2006).
   Google Scholar
• Leyden JJ. Therapy for acne vulgaris. N. Engl. J. Med.336, 1156–1162 (1997).
   PubMed Web of Science ®Google Scholar
• Gollnick H, Cunliffe W, Berson D et al. Management of acnze: a report from a Global Alliance to Improve Outcomes in Acne. J. Am. Acad. Dermatol.49, S1–S37 (2003).
   PubMed Web of Science ®Google Scholar
• Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA291, 827–835 (2004).
   PubMed Web of Science ®Google Scholar
• Hongcharu W, Taylor C, Chang Y et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J. Invest. Dermatol.115, 183–192 (2000).
   PubMed Web of Science ®Google Scholar
• Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolevunic acid. Arch. Dermatol.136, 1093–1095 (2000).
   PubMed Web of Science ®Google Scholar
• Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta-aminolevulinic acid and incoherent light in Japanese patients. Br. J. Dermatol.144, 575–579 (2001).
   PubMed Web of Science ®Google Scholar
• Goldman MP, Boyce SM. A single center study of 5-aminolevulinic acid and 417 nm photodynamic therapy in the treatment of moderate to severe acne vulgaris. J. Drugs Dermatol.2, 393–396 (2003).
   PubMedGoogle Scholar
• Gold MH. A single-center, open-label investigatory study of photodynamic therapy in the treatment of moderate to severe acne vulgaris with aminolevulinic acid topical solution 20% and visible blue light. Poster presentation at the 61st Annual Meeting of the American Academy of Dermatology. CA, USA (2003).
   Google Scholar
• Goldman MP, Boyce SM. A single center study of 5-aminolevulinic acid and 417 nm photodynamic therapy in the treatment of moderate to severe acne vulgaris. J. Drugs Dermatol.2, 393–396 (2003).
   PubMedGoogle Scholar
• Gold MH, Bradshaw VL, Boring MM et al. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris. J. Drugs Dermatol.3(6), S14–S18 (2004).
   Google Scholar
• Taub A. Photodynamic therapy for the treatment of acne: a pilot study. J. Drugs Dermatol.3, S10–S14 (2004).
   PubMedGoogle Scholar
• Alexiades-Armenakas M. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne. J. Drugs Dermatol.5(1), 45–55 (2006).
   PubMedGoogle Scholar
• Santos MA, Belo VG, Santos G. Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone in the treatment of acne vulgaris: comparative study. Dermatol. Surg.31, 910–915 (2005).
   PubMed Web of Science ®Google Scholar
• Rojanamatin J, Choawawanich P. Treatment of inflammatory facial acne vulgaris with intense pulsed light (IPL) and short contact of topical 5-aminolevulinic acid (ALA): a pilot study. Dermatol. Surg. (2005).
   Google Scholar
• Wiegell SR, Wuff HC. Photodynamic therapy of acne vulgaris using methyl aminolevulate – a randomized blinded controlled study. Arch. Dermatol. (2006) (In press).
   Google Scholar
• Horio T, Horio O, Miyauchi-Hashimoto H, Ohnuki M, Isei T. Photodynamic therapy of sebaceous hyperplasia with topical 5-aminolaevulinic acid and slide projector. Br. J. Dermatol.148, 1274–1276 (2003).
   PubMed Web of Science ®Google Scholar
• Alster TS, Tanzi EL. Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia. J. Drugs Dermatol.2(5), 501–504 (2003).
   PubMedGoogle Scholar
• Richey DF, Hopson B. Treatment of sebaceous hyperplasia by photodynamic therapy. Cosmetic Dermatol.17, 525–529 (2004).
   Google Scholar
• Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Lewis TL. Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. J. Drugs Dermatol.3, S6–S9 (2004).
   PubMedGoogle Scholar
• Gold MH, Boring MM, Bridges TM, Bradshaw VL. ALA-PDT and blue light therapy for hidradenitis suppuritiva. J. Drugs Dermatol.3(Suppl.), 32–39 (2004).
   PubMedGoogle Scholar
• Strauss RM, Pollock B, Stables GI, Goulden V, Cunliffe WJ. Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br. J. Dermatol.152(4), 803–804 (2005).
   PubMed Web of Science ®Google Scholar
• Fang JY, Lee WR, Shen SC, Fang YP, Hu CH. Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br. J. Dermatol.151(1), 132–140 (2004).
   PubMed Web of Science ®Google Scholar
• Szeimies RM, Karrer S, Radakovic-Fijan S et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J. Am. Acad. Dermatol.47, 258–262 (2002).
   PubMed Web of Science ®Google Scholar
• Bjerring P, Funk J, Poed-Petersen J, Soderberg U. Randomized double blind study comparing photodynamic therapy (PDT) with Metvix® to PDT with placebo cream in actinic keratosis. Proceedings of the 29th Nordic Congress of Dermatology and Venereology. Gothenborg, June (2001).
   Google Scholar
• Freeman M, Vinciullo C, Francis D et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J. Dermatolog. Treat.14, 99–106 (2003).
   PubMedGoogle Scholar
• Pariser DM, Lowe NJ, Stewart DM et al. Photodynamic therapy with topical methyl aminolevulinate (Metvix®) is effective and safe in the treatment of actinic keratosis: results of a prospective randomized trial. J. Am. Acad. Dermatol.48, 227–232 (2003).
   PubMed Web of Science ®Google Scholar
• Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm. Venereol.85(5), 424–428 (2005).
   PubMed Web of Science ®Google Scholar
• Soler AM, Warloe T, Berner A et al. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl-5-aminolevulinate-based photodynamic therapy alone and with prior curettage. Br. J. Dermatol.145, 467–471 (2001).
   PubMed Web of Science ®Google Scholar
• Rhodes LE, de Rie M, Enstrom Y et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch. Dermatol.140, 17–23 (2004).
   PubMed Web of Science ®Google Scholar
• Basset-Seguin N, Ibbotson S, Emtestam L et al. Photodynamic therapy using Metvix is as efficacious as cryotherapy in BCC, with better cosmetic results. J. Eur. Acad. Dermatol. Venereol.18(Suppl. 2), 413 (2004).
   Google Scholar
• Tope WD, Menter A, El-Azhary RA et al. Comparison of topical methyl aminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular BCC. Poster presentation at the 13th Congress of the European Academy of Dermatology and Venereology. Florence, Italy, November (2004).
   Google Scholar
• Foley P, Freeman M, Siller G et al. MAL-PDT or placebo cream in nodular basal cell carcinoma: results of an Australian double blind randomized multicentre study. Poster presentation at the International Skin Cancer Conference. Zurich, Switzerland, July (2004).
   Google Scholar
• Horn M, Wolf P, Wulf HC et al. Topical methyl aminolevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional therapy. Br. J. Dermatol.149, 1242–1249 (2003).
   PubMed Web of Science ®Google Scholar
• Vinciullo C, Elliott T, Francis D et al. Photodynamic therapy with topical methyl aminolaevulinate for ‘difficult-to-treat’ basal cell carcinoma. Br. J. Dermatol.152(4), 765–772 (2005).
   PubMed Web of Science ®Google Scholar
• Morton CA, Horn M, Leman J et al. A randomised, placebo controlled, European study comparing MAL-PDT with cryotherapy and 5-fluorouracil in subjects with Bowen’s disease: results from a 24 months follow-up. Poster presentation at the 14th Congress of the European Academy of Dermatology and Venereology. London, UK, October (2005).
   Google Scholar